Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

NCT03978624 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Entinostat
PROCEDURE: Procedure/Surgery

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]